In Vitro Diagnostics Market is anticipated to cross a value of US$ 129.9 Billion by 2033, at a steady CAGR of 4.8% from 2023 to 2033 | Future Market Insights, Inc.
24. Februar 2023 05:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The in vitro diagnostics market is likely to thrive at an average CAGR of 4.8% between 2023 and 2033. The market is anticipated to cross a market share...
Vitro Biopharma Appoints Established Life Science Sales Executive to Its Board of Directors
20. Februar 2013 13:25 ET
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, simultaneously accepted the resignation of Mr. Erik Van Horn from its Board of Directors and...
Vitro Biopharma Launches New Stem Cell Products to Accelerate Bone Growth
22. Januar 2013 09:51 ET
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., Jan. 22, 2013 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced the launch of a series of products with application to accelerated bone growth,...
Vitro Biopharma Launches Products for Drug Development & Advancement of Joint Regeneration Technology
09. Oktober 2012 08:45 ET
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the launch of a series of products for use in the development of advanced...
Vitro Biopharma Signs Agreement With StemGenesis for Distribution of Its Stem Cell Products in China
12. September 2012 08:40 ET
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., Sept. 12, 2012 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced an agreement with StemGenesis, Inc. (http://www.stemgenesisinc.com) for the...
Vitro Biopharma Strengthens and Expands Its Distribution Agreement With Neuromics
24. Juli 2012 08:55 ET
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., July 24, 2012 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced an expanded relationship with a key distributor of its stem cell-based products,...